P&G Beats as Volume Grows for First Time in a Year
Procter & Gamble posts Q3 EPS of $1.63 vs $1.56 expected. Revenue hits $21.24B. Volume rises 2%, marking first growth in four quarters.
Procter & Gamble just proved the consumer isn't dead—at least not yet.
The consumer goods giant reported fiscal Q3 results Friday morning that beat on both revenue and earnings while delivering something analysts hadn't seen in four quarters: volume growth. Shares jumped 4% in premarket trading.
Revenue came in at $21.24 billion versus the $20.5 billion consensus, up 3.6% year-over-year. Adjusted EPS of $1.63 topped the $1.56 estimate. But the real headline was volume—up 2%, marking the first positive reading since Q3 fiscal 2025.
The Numbers
| Metric | Actual | Estimate | YoY Change |
|---|---|---|---|
| Revenue | $21.24B | $20.5B | +3.6% |
| EPS (adj) | $1.63 | $1.56 | +4.5% |
| Volume | +2% | ~flat | First growth in 4Q |
| Organic Sales | +4% | +3% | Beat |
Volume growth matters because it signals demand expansion rather than price increases. P&G raised prices aggressively over the past two years to offset input cost inflation. Those increases worked—consumers kept buying Tide and Pampers despite higher prices. But volume had stagnated.
This quarter broke that pattern. Consumers bought more products, not just more expensive products. That's a healthier growth profile.
Category Performance
Beauty led the way with mid-single-digit organic growth. Premium skincare brands SK-II and Olay continued gaining share globally. The category benefits from consumer willingness to splurge on personal care even while tightening other spending.
Fabric and home care—P&G's largest segment—grew low-single digits. Tide held share against private-label competition despite a persistent price gap. P&G's manufacturing scale creates cost advantages that store brands can't match.
Healthcare surprised to the upside, driven by respiratory product sales and oral care strength. Vicks and Crest both posted growth.
Baby care remained challenged. Pampers sales were roughly flat as birth rates stay depressed and competitors offer cheaper alternatives. This segment has struggled for years, and management offered no timeline for improvement.
The Tariff Update
When P&G reported Q2 results in January, management flagged approximately $1 billion in tariff-related costs for fiscal 2026. That guidance hasn't changed.
The company continues absorbing some costs through productivity initiatives while passing others to consumers. So far, the price increases haven't destroyed demand—this quarter's volume growth suggests consumers are adjusting.
But P&G isn't immune to economic uncertainty. If consumer confidence deteriorates or employment weakens, the demand picture could shift quickly. For now, the company is navigating economic headwinds better than bears expected.
Guidance Implications
P&G maintained full-year adjusted EPS guidance around $6.96 at the midpoint. Revenue should grow 3-4% organically. Nothing changed, but the context improved.
When guidance was set, questions lingered about whether P&G could hit targets without volume growth. Those questions are quieter now. The company demonstrated it can grow units while maintaining pricing—the ideal scenario for consumer staples.
Operating margin of 23.8% came in slightly below last year but above Q2 levels. The sequential improvement suggests cost pressures are peaking rather than accelerating.
What It Means for the Sector
P&G's results provide a read-through for consumer staples broadly. If the largest player can grow volume while maintaining pricing, smaller competitors likely face similar dynamics.
For investors debating consumer resilience, P&G offers evidence that demand remains intact. The American consumer keeps spending on household essentials despite inflation, tariffs, and economic uncertainty. That resilience has defied skeptics for two years now.
The stock trades at 24 times forward earnings, a premium to the consumer staples sector average of roughly 20x. The valuation requires continued execution—volume growth, margin stability, and dividend increases. This quarter checked all boxes.
The Bigger Picture
Consumer staples stocks traded sideways for most of 2025 while growth stocks rallied. The sector became a source of funds for AI and tech bets. P&G underperformed the S&P 500 despite defensive characteristics.
That dynamic may be shifting. As growth stocks face valuation scrutiny and market volatility increases, defensive names with predictable cash flows attract renewed interest. P&G's 68-year streak of consecutive dividend increases offers stability that growth investors can't match.
Friday's results won't transform P&G into a momentum stock. But they confirm the company remains the gold standard in consumer goods—executing consistently while others struggle with the same pressures.
For long-term shareholders, that's exactly what matters. P&G doesn't need to surprise. It needs to deliver. This quarter, it did.